Texas Hemp Ban: Legal Status, Business Impact & Consumer Rights

Executive Summary

Texas has become ground zero for hemp regulatory chaos, with state officials imposing, suspending, and reimposing restrictions on intoxicating hemp products multiple times since 2023, leaving businesses and consumers in legal limbo. The state's Department of State Health Services (DSHS) has attempted to ban products containing delta-8 THC, delta-9 THC above 0.3%, and other hemp-derived cannabinoids through emergency rules and permanent regulations, only to face repeated legal challenges and court injunctions. As of May 2026, retailers across Texas face conflicting guidance on whether they can legally sell hemp flower, pre-rolls, and intoxicating edibles, with enforcement varying by jurisdiction and date. The regulatory whiplash has created a multi-million dollar compliance crisis for the state's estimated 2,000+ hemp retailers, while lawmakers debate comprehensive legislation to either legitimize and regulate the market or shut it down entirely. The outcome will determine whether Texas joins states embracing regulated hemp markets or becomes one of the few to effectively prohibit products federally legalized under the 2018 Farm Bill.

Why This Matters

The Texas hemp ban affects a $500 million annual market serving millions of consumers who rely on legal hemp products for wellness, recreation, and medical purposes in a state without adult-use cannabis legalization. Texas has emerged as one of the nation's largest hemp markets by population, with hemp-derived delta-8 THC and other cannabinoids filling the void left by the state's prohibition of recreational marijuana and its restrictive medical cannabis program limited to low-THC products for specific conditions.

The regulatory uncertainty impacts multiple stakeholder groups. Small business owners have invested millions in inventory, leases, and licensing fees, only to face potential criminal liability as rules change. Consumers who turned to legal hemp products—many seeking alternatives to prescription medications or black-market cannabis—now face supply disruptions and legal ambiguity about possession. Agricultural producers who planted hemp crops under federal and state authorization face collapsed wholesale markets as retailers pull products from shelves. Industry employees, numbering in the thousands across retail, manufacturing, and distribution, face job insecurity.

The financial stakes extend beyond direct market participants. Texas collects sales tax revenue from hemp transactions, and local governments have issued business permits and zoning approvals. Banks and payment processors serving hemp businesses face compliance questions. Landlords leasing to hemp retailers worry about property seizures under nuisance laws. The legal confusion has also created enforcement challenges for local police and prosecutors uncertain about which products remain legal.

Beyond economics, the Texas situation represents a critical test case for federalism and the 2018 Farm Bill's hemp provisions. If states can effectively ban intoxicating hemp products through health and safety regulations, it undermines the federal framework that legalized hemp and its derivatives. The Texas approach—using state agency rulemaking rather than legislative action—also raises questions about administrative authority and separation of powers that resonate beyond cannabis policy.

Background and History

The Texas hemp ban emerged from an unintended consequence of the state's 2019 hemp legalization, which created a legal pathway for intoxicating cannabinoids that lawmakers never anticipated.

2018 Federal Farm Bill Creates Hemp Loophole

The story begins with the Agriculture Improvement Act of 2018, commonly called the 2018 Farm Bill, signed by President Trump on December 20, 2018. Section 10113 of that law removed hemp—defined as cannabis containing no more than 0.3% delta-9 THC on a dry-weight basis—from Schedule I of the Controlled Substances Act (21 U.S.C. § 812). This federal legalization created a distinction between marijuana (cannabis above 0.3% delta-9 THC) and hemp (cannabis at or below that threshold), making hemp an agricultural commodity rather than a controlled substance.

The 0.3% threshold, based on a 1976 Canadian research paper, measured only delta-9 THC in plant material. This narrow definition inadvertently left other intoxicating cannabinoids unregulated, including delta-8 THC (a naturally occurring but typically minor cannabinoid that can be synthesized from CBD), THC-O, THCP, and others. Entrepreneurs quickly recognized this regulatory gap and began producing intoxicating hemp products through chemical conversion processes.

2019: Texas House Bill 1325 Legalizes Hemp

On June 10, 2019, Texas Governor Greg Abbott signed House Bill 1325 into law, aligning Texas statutes with the federal Farm Bill by legalizing hemp cultivation, processing, and sales. The bill, sponsored by Representative Tracy King, amended the Texas Health and Safety Code to define hemp using the federal 0.3% delta-9 THC standard and removed hemp from the state's controlled substances schedules.

HB 1325 created the Texas Department of Agriculture's hemp program for licensing growers and established the DSHS as the regulatory authority for hemp manufacturing and retail. The law required DSHS to adopt rules for consumable hemp products but provided minimal guidance on intoxicating cannabinoids. Legislators focused primarily on industrial hemp applications—fiber, seed, and CBD—with little discussion of psychoactive potential.

The law's passage had an immediate unintended effect on marijuana enforcement. Because hemp and marijuana are visually and chemically identical without laboratory testing, prosecutors across Texas began dismissing low-level possession cases, lacking the resources to test whether seized cannabis exceeded 0.3% delta-9 THC. District attorneys in Harris County, Travis County, and other jurisdictions announced they would no longer prosecute most misdemeanor marijuana cases.

2020-2021: Delta-8 Market Explodes

Between 2020 and 2021, delta-8 THC products flooded the Texas market. Manufacturers used chemical processes to convert CBD isolate (derived from legal hemp) into delta-8 THC, an intoxicating cannabinoid that produces effects similar to delta-9 THC but was technically legal under the narrow statutory definition. Gas stations, smoke shops, and dedicated hemp retailers began selling delta-8 gummies, vapes, tinctures, and flower.

The market grew with minimal oversight. Products lacked standardized testing, potency labeling, or age restrictions in many jurisdictions. Reports of adverse events began reaching poison control centers, including cases involving children who consumed delta-8 edibles resembling candy. Public health officials and law enforcement expressed concern, but the legislature did not address the issue during the 2021 regular session.

October 2021: DSHS Issues First Ban Attempt

On October 15, 2021, DSHS updated its Consumable Hemp Program website to declare delta-8 THC and other "chemically modified" cannabinoids illegal under Texas law. The agency argued that the Texas Controlled Substances Act's definition of marijuana included "all isomers" of THC, which would encompass delta-8. This interpretation contradicted the hemp industry's reading of HB 1325 and federal law.

The announcement created immediate confusion. Some retailers pulled products; others continued sales, arguing DSHS lacked authority to reinterpret statute through website posts. No formal rulemaking process occurred, and no enforcement actions immediately followed. The Texas Hemp Federation and other industry groups challenged the interpretation, arguing that delta-8 derived from legal hemp was explicitly protected under both state and federal law.

2023 Legislative Session: Reform Efforts Fail

During the 2023 Texas legislative session (January through May), multiple bills attempted to address intoxicating hemp products. House Bill 3948, filed by Representative Lacey Hull, would have banned delta-8 and other intoxicating hemp cannabinoids while creating a regulated adult-use cannabis market. Senate Bill 1008 proposed age restrictions and testing requirements for hemp products without banning them outright. House Bill 1535 sought to clarify that all hemp derivatives were legal regardless of intoxication potential.

None of these bills passed. Conservative Republicans opposed cannabis legalization in any form, while hemp industry advocates fought restrictions on existing products. Law enforcement groups pushed for bans, citing youth access concerns. The legislative stalemate left DSHS as the primary regulatory authority, with no clear statutory guidance on intoxicating cannabinoids beyond the original HB 1325 language.

September 2023: Emergency Rules Imposed

On September 1, 2023, DSHS implemented emergency rules under Texas Government Code § 2001.034, which allows agencies to adopt rules without standard notice-and-comment procedures when an "imminent peril to public health, safety, or welfare" exists. The emergency rules, published in the Texas Register, prohibited the manufacture and sale of consumable hemp products containing:

• Delta-8 THC, delta-9 THC, or delta-10 THC in any amount
• Any "chemically modified or converted" cannabinoids
• Total THC exceeding 0.5 milligrams per serving or 2 milligrams per package
• Hemp flower or pre-rolled joints intended for smoking

The rules gave retailers 60 days to comply, requiring removal of thousands of products from store shelves. DSHS cited 1,500+ calls to poison control centers involving hemp products between 2021 and 2023 as justification for emergency action. The agency argued that intoxicating hemp products posed particular risks to children and that the unregulated market created public health hazards.

November 2023: First Court Injunction

On November 3, 2023, Travis County District Judge Jan Soifer issued a temporary restraining order blocking enforcement of the emergency rules. The order came in response to a lawsuit filed by Hometown Hero CBD, a Texas-based hemp manufacturer, along with other industry plaintiffs represented by the law firm Ritter Spencer Cheng. The plaintiffs argued that DSHS exceeded its statutory authority, violated administrative procedure requirements, and contradicted federal hemp law.

Judge Soifer found that plaintiffs demonstrated a probable right to relief and that they would suffer irreparable harm from the rules' enforcement. The TRO allowed hemp businesses to resume sales of previously banned products while the case proceeded. DSHS appealed but did not obtain a stay, leaving the injunction in effect through the end of 2023.

January 2024: Permanent Rules Adopted

On January 12, 2024, DSHS adopted permanent rules through the standard rulemaking process, incorporating public comments and making minor modifications to the September 2023 emergency provisions. The permanent rules, codified at 25 Texas Administrative Code § 229, maintained prohibitions on delta-8 THC, smokable hemp flower, and products exceeding specified THC limits. DSHS argued the permanent rules addressed procedural objections to the emergency version while maintaining necessary public health protections.

The permanent rules added testing and labeling requirements for compliant products, including batch-specific certificates of analysis, child-resistant packaging, and warning labels. Products containing CBD and other non-intoxicating cannabinoids remained legal if they met the THC thresholds. The rules established a registration system for manufacturers and retailers, with fees ranging from $1,000 to $5,000 depending on business type.

March 2024: Second Injunction Issued

On March 18, 2024, Judge Soifer issued a preliminary injunction blocking the permanent rules, finding that DSHS likely exceeded its statutory authority under HB 1325. The 47-page order concluded that the Texas Legislature, not DSHS, must decide whether to ban intoxicating hemp products. Judge Soifer noted that the legislature had multiple opportunities to address the issue and chose not to enact prohibitions, suggesting legislative intent to allow such products under the federal framework.

The ruling emphasized that DSHS's authority under HB 1325 extended to "consumable hemp products" but did not grant blanket authority to ban entire product categories based on intoxication potential. The judge distinguished between regulating product safety (testing, labeling, age restrictions) and prohibiting products altogether. The preliminary injunction remained in effect pending final judgment, again allowing hemp retailers to sell previously banned items.

May 2025: Appeals Court Weighs In

On May 22, 2025, the Third Court of Appeals in Austin heard oral arguments in DSHS's appeal of the preliminary injunction. A three-judge panel questioned both sides about the scope of agency authority under Texas administrative law and whether the federal Farm Bill preempted state restrictions on hemp derivatives. The state argued that its police powers allowed regulation of intoxicating substances regardless of federal hemp legalization, while industry attorneys contended that Texas law explicitly adopted the federal framework without additional restrictions.

The appeals court did not issue an immediate ruling, leaving the preliminary injunction in place. Legal observers noted that the case could ultimately reach the Texas Supreme Court, with implications for administrative law and federalism extending beyond cannabis policy. The prolonged litigation created ongoing uncertainty, as businesses operated under an injunction that could be reversed at any time.

September 2025: Enforcement Crackdown Begins

In September 2025, despite the ongoing injunction, some local law enforcement agencies began seizing hemp products and citing retailers under pre-HB 1325 marijuana statutes. Police in Lubbock, Amarillo, and several smaller cities argued that delta-8 products constituted marijuana under the "all isomers" language of the Texas Controlled Substances Act, regardless of hemp derivation. These enforcement actions created a patchwork of local policies, with hemp products legal in Austin and Houston but subject to seizure in West Texas.

The Texas Hemp Federation documented 37 separate enforcement incidents between September and December 2025, including product seizures totaling an estimated $2.3 million in retail value. Some district attorneys declined to prosecute cases, citing the legal uncertainty, while others moved forward with charges. Defense attorneys argued that the preliminary injunction provided legal cover for retailers, but prosecutors countered that the injunction only blocked DSHS rules, not underlying criminal statutes.

January 2026: New Legislative Session Opens

The 2026 Texas legislative session, which began on January 14, 2026, brought renewed attention to hemp regulation. Multiple bills were filed, including House Bill 2796 by Representative Joe Moody, which would explicitly legalize and regulate intoxicating hemp products with age restrictions, testing requirements, and potency limits. Senate Bill 645, filed by Senator Charles Schwertner, took the opposite approach, proposing to ban all intoxicating hemp cannabinoids and authorize criminal penalties for violations.

As of May 2026, neither bill had advanced from committee. Republican leadership remained divided, with rural members supporting hemp agriculture and urban conservatives opposing intoxicating products. Democratic legislators generally favored regulation over prohibition but lacked the votes to pass legislation without Republican support. Industry lobbyists, public health advocates, and law enforcement groups testified at multiple committee hearings, but no consensus emerged.

May 2026: On-Again, Off-Again Enforcement

On May 16, 2026, reports emerged of renewed confusion as DSHS issued guidance suggesting the preliminary injunction might not apply to all product categories. Hemp retailers in Dallas, San Antonio, and other cities received conflicting information from local health departments about which products remained legal. Some jurisdictions interpreted the injunction narrowly, allowing delta-8 edibles but not smokable flower, while others took a broader view permitting all hemp-derived cannabinoids below federal THC thresholds.

Industry representatives described the situation as "Texas whiplash," with businesses unable to plan inventory, negotiate leases, or secure financing amid constant regulatory shifts. Lukas Gilkey, CEO of Hometown Hero CBD and lead plaintiff in the ongoing litigation, stated that retailers "don't know what is going to happen one day to the next" and simply want "certainty and to sell their products." The regulatory chaos prompted some national hemp brands to exit the Texas market entirely, while others continued operations under legal uncertainty.

Key Players

Texas Department of State Health Services (DSHS)

DSHS serves as the primary regulatory authority for consumable hemp products under HB 1325, but its aggressive rulemaking has sparked the legal battle over intoxicating cannabinoids. The agency, led by Commissioner Jennifer Shuford (appointed 2023), argues that its mandate to protect public health authorizes restrictions on intoxicating hemp products, particularly those marketed in ways that appeal to children. DSHS has cited poison control data, lack of product standardization, and youth access concerns as justification for emergency and permanent rules. The agency maintains that its regulations comply with federal law while addressing state-specific public health needs.

Critics, including industry groups and some legal scholars, contend that DSHS exceeded its statutory authority by effectively banning product categories that the legislature chose to leave legal. The agency's use of emergency rulemaking and its shifting interpretations of the preliminary injunction have drawn particular criticism. DSHS has defended its approach as necessary given legislative inaction and the evolving hemp market.

Texas Department of Agriculture (TDA)

The TDA, under Commissioner Sid Miller, oversees hemp cultivation and has generally supported the industry. Miller, a Republican known for libertarian positions on agriculture issues, has publicly criticized DSHS rules as overreach that harms Texas farmers. The TDA licenses hemp growers under the U.S. Department of Agriculture's approved state plan and conducts field inspections to verify THC compliance. As of 2026, Texas had approximately 3,200 licensed hemp growers cultivating an estimated 18,000 acres, primarily for CBD extraction and biomass production.

The regulatory conflict has created tension between TDA and DSHS, with farmers caught in the middle. Growers who planted hemp for the cannabinoid market face collapsed demand as retailers pull products, while those focused on fiber and grain markets remain largely unaffected. Commissioner Miller has called for legislative clarity and suggested that Texas should follow the regulatory model of states like Colorado or Oregon rather than pursuing prohibition.

Hometown Hero CBD and Industry Plaintiffs

Hometown Hero CBD, based in Austin, emerged as the lead plaintiff challenging DSHS rules. Founded in 2015 by veterans Lukas Gilkey and Jared Dyer, the company manufactures and distributes hemp-derived products across Texas and nationally. Hometown Hero joined forces with other Texas hemp businesses, including Drip Cannabinoids, Danodan, and the Texas Hemp Coalition, to file suit in Travis County District Court in October 2023.

The plaintiffs argue that DSHS rules contradict the plain language of HB 1325 and federal hemp law, violate Texas Administrative Procedure Act requirements, and constitute an unconstitutional delegation of legislative authority. Their legal team, led by attorney Ritter Spencer Cheng, has successfully obtained two injunctions blocking enforcement. The case has become a rallying point for the hemp industry nationwide, as other states watch to see whether Texas's regulatory approach survives judicial scrutiny.

Texas Hemp Federation

The Texas Hemp Federation, a trade association representing growers, manufacturers, and retailers, has advocated for clear regulations rather than prohibition. The organization, which claims over 500 member businesses, has lobbied the legislature for comprehensive hemp legislation and supported the legal challenge to DSHS rules. Executive Director Jason Miller (no relation to Commissioner Sid Miller) has testified at legislative hearings and worked with lawmakers on proposed regulatory frameworks.

The Federation has proposed a model similar to alcohol regulation, with age restrictions (21+), testing requirements, potency limits, and retail licensing. The organization argues that prohibition drives consumers to unregulated black markets while regulation ensures product safety and generates tax revenue. The Federation has also emphasized the economic impact of the hemp industry, citing a 2025 study estimating 8,500 direct jobs and $500 million in annual sales.

Law Enforcement and Prosecutors

Texas law enforcement groups, including the Texas Police Chiefs Association and the Sheriffs' Association of Texas, have generally supported DSHS restrictions. These organizations cite concerns about impaired driving, youth access, and the difficulty of distinguishing legal hemp from illegal marijuana in the field. Some prosecutors, particularly in conservative rural counties, have pushed for stricter enforcement and clearer prohibitions.

However, district attorneys in major urban counties have taken varied approaches. Travis County DA José Garza and Harris County DA Kim Ogg have declined to prosecute most hemp-related cases given the legal uncertainty. Dallas County DA John Creuzot has focused enforcement on unlicensed operators and products marketed to children while allowing compliant retailers to operate. This patchwork of enforcement policies reflects broader divisions within Texas law enforcement about cannabis policy.

Public Health Advocates

Organizations including the Texas Medical Association, Texas Pediatric Society, and Texas Public Health Association have supported DSHS restrictions, emphasizing concerns about product safety, youth access, and lack of clinical research on hemp-derived cannabinoids. These groups have cited FDA warnings about delta-8 THC and other converted cannabinoids, noting that manufacturing processes may introduce contaminants and that products often contain higher THC levels than labels indicate.

Public health advocates have called for comprehensive regulation including mandatory testing, child-resistant packaging, potency limits, and age verification. Some support prohibition of smokable products and high-potency edibles while allowing lower-dose CBD products. The public health community remains divided between those who view harm reduction through regulation as preferable to prohibition and those who believe intoxicating hemp products should be banned pending further research.

Legal and Regulatory Framework

The Texas hemp ban operates at the intersection of federal hemp law, state statutes, administrative rules, and ongoing litigation, creating a complex and often contradictory legal landscape.

Federal Framework: The 2018 Farm Bill

The Agriculture Improvement Act of 2018 (Pub. L. 115-334) established the federal foundation by amending the Controlled Substances Act to exclude hemp, defined as cannabis containing no more than 0.3% delta-9 THC on a dry-weight basis. Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. § 1639o) prohibits states from restricting interstate commerce in hemp or hemp products that comply with federal standards. This preemption provision has become central to legal challenges against state bans.

The U.S. Department of Agriculture (USDA) regulates hemp cultivation under 7 CFR Part 990, requiring states to submit plans for approval. The FDA maintains authority over hemp-derived products marketed as food, dietary supplements, or drugs under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. § 301 et seq.). The FDA has issued warning letters to companies making therapeutic claims about CBD and delta-8 products but has not established comprehensive regulations for hemp-derived cannabinoids in consumer products.

Texas House Bill 1325 (2019)

HB 1325 amended Texas Health and Safety Code § 443 to create the state's hemp program. Key provisions include:

• Definition of hemp matching federal law: cannabis with no more than 0.3% delta-9 THC
• Removal of hemp from controlled substances schedules (Health and Safety Code § 481.002)
• Authorization for TDA to license hemp growers
• Requirement for DSHS to adopt rules for consumable hemp products
• Prohibition on local governments banning hemp cultivation or sales

The statute grants DSHS authority to regulate "the manufacture, processing, distribution, and sale of consumable hemp products" but does not explicitly authorize bans on product categories. This ambiguity has fueled the legal dispute, with DSHS arguing that regulatory authority includes prohibition power and industry plaintiffs contending that the legislature must enact specific bans.

Texas Controlled Substances Act

The Texas Controlled Substances Act (Health and Safety Code Chapter 481) defines marijuana as "the plant Cannabis sativa L., whether growing or not, the seeds of that plant, and every compound, manufacture, salt, derivative, mixture, or preparation of that plant or its seeds" (§ 481.002(26)). The definition includes "all isomers" of THC, which DSHS has interpreted to encompass delta-8 and other THC variants.

However, HB 1325 created an exception by removing hemp from this definition. The legal question is whether hemp-derived cannabinoids, even if intoxicating, fall under the hemp exception or remain controlled substances under the "all isomers" language. Courts have not definitively resolved this issue, though Judge Soifer's preliminary injunction suggests that the hemp exception prevails.

DSHS Rules: 25 Texas Administrative Code § 229

The permanent DSHS rules, adopted January 2024 but currently enjoined, establish detailed requirements for consumable hemp products:

• Prohibition on products containing delta-8 THC, delta-9 THC, delta-10 THC, or other "artificially derived" cannabinoids
• THC limits: no more than 0.5 mg per serving or 2 mg per package for compliant products
• Ban on smokable hemp flower and pre-rolled joints
• Mandatory third-party testing for potency, pesticides, heavy metals, and microbials
• Child-resistant packaging requirements
• Warning labels about intoxication, pregnancy risks, and driving impairment
• Registration requirements for manufacturers and retailers
• Prohibition on marketing that appeals to minors

The rules also establish inspection authority and penalties for violations, including license revocation and civil fines up to $25,000 per violation. Criminal penalties under existing statutes could also apply to banned products.

Ongoing Litigation: Hometown Hero v. DSHS

The case, filed in Travis County District Court (Cause No. D-1-GN-23-005479), challenges both the emergency and permanent DSHS rules. Plaintiffs assert claims under the Texas Administrative Procedure Act (Government Code Chapter 2001), arguing that DSHS failed to demonstrate "imminent peril" justifying emergency rules and that the permanent rules exceed statutory authority. Additional claims include violations of due process, unlawful delegation of legislative power, and conflict with federal preemption under the Supremacy Clause.

Judge Soifer's March 2024 preliminary injunction found that plaintiffs demonstrated a substantial likelihood of success on the merits, particularly on the ultra vires (beyond authority) claim. The court noted that the legislature had considered and rejected hemp restrictions during multiple sessions, suggesting that DSHS lacked authority to impose prohibitions through rulemaking. The case remains pending, with a trial on the merits not yet scheduled as of May 2026.

Federal Preemption Questions

A key unresolved issue is whether the 2018 Farm Bill preempts state restrictions on hemp products. Section 297A's prohibition on states restricting interstate hemp commerce could be interpreted to bar Texas from banning hemp-derived cannabinoids that comply with federal THC limits. However, states retain traditional police powers to regulate intoxicating substances, and the Farm Bill does not explicitly address state authority over psychoactive hemp products.

The Tenth Amendment reserves to states powers not delegated to the federal government, which could support Texas's authority to regulate intoxicating substances regardless of federal hemp legalization. This federalism tension mirrors debates over state marijuana legalization despite federal prohibition, but in reverse—here, the federal government has legalized a substance (hemp) that states seek to restrict. No federal court has definitively resolved this preemption question in the hemp context.

Market and Business Implications

The regulatory uncertainty has devastated Texas hemp businesses while creating opportunities for black-market operators and out-of-state competitors. The state's estimated 2,000 hemp retailers face impossible compliance decisions: follow DSHS rules and remove profitable products, or continue sales under the injunction and risk future enforcement.

Financial Impact on Retailers

Hemp retailers have invested heavily in inventory, store buildouts, and licensing. A typical retail location carries $50,000 to $150,000 in product inventory, with delta-8 and other intoxicating cannabinoids representing 60-80% of sales volume according to industry surveys. The September 2023 emergency rules forced retailers to either destroy inventory or warehouse it pending legal resolution, creating immediate cash-flow crises.

Many retailers took out loans to stock inventory during periods when products were legal, only to face potential losses when rules changed. Banks and lenders, already cautious about cannabis-adjacent businesses, have tightened credit standards for Texas hemp operators. Some retailers have filed for bankruptcy protection, while others have pivoted to CBD-only products with significantly lower profit margins. The Texas Hemp Federation estimates that 300-400 retail locations closed between September 2023 and May 2026 due to regulatory uncertainty.

Wholesale Market Collapse

Texas hemp farmers who planted crops for the cannabinoid market have seen wholesale prices collapse. CBD biomass that sold for $300-500 per pound in 2022 now fetches $50-100 per pound, while demand for hemp flower suitable for delta-8 conversion has virtually disappeared. Processors who invested in extraction equipment and conversion chemistry face stranded assets and canceled contracts.

The wholesale market disruption extends beyond Texas. Hemp grown in other states and processed into delta-8 products for Texas distribution has lost a major market. National brands including 3Chi, Hometown Hero, and Urb have reduced or eliminated Texas operations. Some manufacturers have shifted production to states with clearer regulatory frameworks, including Colorado, Oregon, and Michigan.

Black Market Growth

Prohibition and regulatory uncertainty have predictably driven growth in unregulated markets. Consumers seeking delta-8 and other hemp cannabinoids have turned to online retailers shipping from states without restrictions, unlicensed local operators, and traditional marijuana dealers. These black-market products lack testing, quality control, or age verification, creating the public health risks that DSHS rules purportedly address.

Law enforcement officials report increased seizures of counterfeit hemp products, including vapes and edibles containing synthetic cannabinoids or higher THC levels than labels indicate. The regulatory chaos has made it nearly impossible to distinguish legal from illegal products, complicating enforcement. Some prosecutors argue that clear prohibition would be easier to enforce than the current ambiguous regime.

Multi-State Operator (MSO) Strategies

Large cannabis companies have taken varied approaches to the Texas hemp market. Some MSOs, including Curaleaf and Trulieve, have avoided Texas entirely given the regulatory uncertainty and their focus on state-licensed medical and adult-use markets. Others, including Parallel and Ayr Wellness, have explored hemp retail as a potential entry point if Texas eventually legalizes adult-use cannabis.

The regulatory instability has made Texas less attractive for cannabis investment compared to states with established legal frameworks. Venture capital and private equity firms that funded hemp startups in 2020-2022 have largely exited the Texas market. Some investors have written off Texas investments entirely, while others maintain positions betting on eventual legislative resolution.

Real Estate and Ancillary Services

The hemp market disruption has affected commercial real estate, particularly in retail corridors where hemp shops clustered. Landlords face tenant defaults and difficulty re-leasing spaces associated with cannabis. Some property owners have inserted lease clauses prohibiting hemp sales, while others have embraced the category given higher rents than traditional retail tenants pay.

Ancillary service providers—including attorneys, accountants, marketing agencies, and security companies—have also felt the impact. Law firms specializing in cannabis and hemp have seen increased demand for regulatory compliance advice but decreased transactional work as deals collapse. Testing laboratories have lost revenue as manufacturers reduce production. The ripple effects extend throughout the Texas economy.

Tax Revenue Implications

Texas collects 6.25% sales tax on hemp products, with local jurisdictions adding up to 2% additional tax. Based on industry estimates of $500 million in annual hemp sales, the state collected approximately $31 million in sales tax revenue in 2025. This revenue stream faces elimination if comprehensive bans take effect, though some argue that tax revenue should not drive policy decisions about intoxicating substances.

Proponents of regulation rather than prohibition point to potential excise tax revenue if Texas adopted a framework similar to alcohol or tobacco. A 10% excise tax on hemp cannabinoids could generate $50 million annually, funds that could support public health programs, substance abuse treatment, or education. However, no legislative proposal has advanced that would create such a tax structure.

What Experts Say

Legal scholars, public health researchers, and industry analysts offer sharply divergent perspectives on the Texas hemp ban, reflecting broader debates about cannabis policy and administrative authority.

Professor Robert Mikos of Vanderbilt Law School, an expert on marijuana federalism, has